Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review Journal Articles uri icon

  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All


  • Key Points The quality of evidence pertaining to the risk of recurrent thrombosis among patients with an antiphospholipid antibody is very low. Additional studies are needed to define the impact of APLA testing on clinical decision-making.


  • Garcia, David
  • Akl, Elie
  • Carr, Richard
  • Kearon, Clive

publication date

  • 2013

published in